CORDIS · 101115525 · HORIZON
Blood2Power Blood as energy source to power smart cardiac devices
Coordinator: I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO (PT)
Cardiovascular diseases (CVD) are the leading cause of death globally, taking 18.6M lives/yr. Most CVD are associated with blockage ofblood vessels. grafts play a vital role, replacing/bypassing these vessels, but have failure rates up to 50% due to thrombosis or infection. Vascular grafts of the future would ideally sense and monitor its performance, and telemetrically emit data/alerts to healthcare system so that medical actions can be performed to avoid graft failure. IoMTs has taken its first steps, but is still far from full potential/development, especially in implantable systems which …
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
EU contribution: €2.9M awarded to the consortium. The project runs over approximately 3 years from 2023-10-01 to 2026-09-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from PT
see all →- Smart4Health — Citizen-centred EU-EHR exchange for personalised health826117 · H2020 · €21.8M
- GIMM-CARE — GIMM-CARE: BOOSTING CLINICAL RESEARCH FOR THE BENEFIT OF SOCIETY101060102 · HORIZON · €15.0M
- MIA-Portugal — Multidisciplinary Institute of Ageing - Portugal857524 · H2020 · €15.0M
- INESCTEC.OCEAN — Centre of Excellence in Ocean Research and Engineering101136903 · HORIZON · €15.0M
- NIMSB — NOVA Institute for Medical Systems Biology101060346 · HORIZON · €15.0M
- BIOPOLIS — Teaming to Upgrade to Excellence in Environmental Biology, Ecosystem Research and AgroBiodiversity857251 · H2020 · €15.0M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-EIC funding scheme.
- What is the EU contribution?
- The European Commission contributes €2.9M toward a total project budget of €2.9M.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call HORIZON-EIC-2022-PATHFINDERCHALLENGES-01.
- Who coordinates the project?
- The project is coordinated by I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO (PT).
- What is the project timeline?
- The project runs from 2023-10-01 to 2026-09-30 — approximately 3 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101115525.